As mentioned above, tumor with high B2M expression had increased MHC-I-based antigen presentation and associated CD8 cytolytic responses, which gliomas were likely to adopt immune evasive mechanisms through expression of immune checkpoint molecules. This evidence concerns the gene CD8A and central nervous system cancer.